Freshpet Q3 sales up 14% to $288.8 million; 2025 adjusted EBITDA guidance lowered
Freshpet reported third-quarter 2025 net sales of $288.8 million, up 14.0% from a year earlier, and net income of $101.7 million, which includes a $77.9 million tax benefit from releasing a valuation allowance. The company narrowed its full-year 2025 net sales growth outlook to about 13% and cut its Adjusted EBITDA range to $190 million to $195 million from $190 million to $210 million, while lowering its capital expenditure plan to about $140 million from about $175 million. Shareholders get higher sales but a lower top end for profit guidance, and the reported net income gain depends on a one-time tax item.
Key points
- Q3 net sales rose 14.0% to $288.8 million; Q3 Adjusted EBITDA was $54.6 million versus $43.5 million a year earlier
- Q3 net income of $101.7 million includes a discrete $77.9 million tax benefit; Q3 gross margin was 39.5% versus 40.4%
- 2025 Adjusted EBITDA guidance is $190 million to $195 million, versus $190 million to $210 million previously
- 2025 capital expenditure guidance is about $140 million, down from about $175 million; the company expects to be free cash flow positive for 2025
The filing
Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 03, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.